| Literature DB >> 35264647 |
Sima Hassani1, Mir-Hassan Moosavy2, Sahar Nouri Gharajalar3, Seyed Amin Khatibi1, Abolfazl Hajibemani4, Zahra Barabadi5.
Abstract
This study aimed to investigate the prevalence of foodborne pathogenic bacteria in bovine milk, their antibiogram phenotype, and the carriage of antibiotic resistance genes. Raw bovine milk samples (n = 100) were randomly collected from different suppliers in the northwest of Iran. Antibiotic-resistant patterns and the presence of antibiotic resistance genes were evaluated in the isolates. Escherichia coli, Listeria monocytogenes, Staphylococcus aureus, and Salmonella spp. were isolated from 78%, 47%, 25%, and 21% of samples, respectively. All isolates showed high rates of resistance to amoxicillin, penicillin, and cefalexin. The blaTEM and blaSHV genes were detected in 50.0% and 6.4% of E. coli isolates, respectively. Also, 28.5% and 19.0% of Salmonella isolates were positive for blaTEM and blaSHV. The frequency of mecA and blaZ in S. aureus isolates was 20.0% and 12.0%, respectively. The high prevalence of bovine milk contamination with antimicrobial-resistant species in this study necessitates precise control on antibiotic prescription in veterinary medicine.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35264647 PMCID: PMC8907330 DOI: 10.1038/s41598-022-07845-6
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996
PCR sets used for detection of target antibiotic-resistance genes in the selected foodborne bacterial isolated from bovine milk.
| Genes | Primer sequence (5' → 3') | Accession number (GenBank) | Annealing (°C) | Amplicon size (bp) | References |
|---|---|---|---|---|---|
| F:ATC AGC AAT AAA CCA GC | NG_068216.1 | 54 | 516 | Eid and Samir[ | |
| R: CCC CGA AGA ACG TTT TC | |||||
| F: AGG ATT GAC TGC CTT TTTG | NG_068212.1 | 54 | 392 | Yukawa et al.[ | |
| R: ATT TGC TGA TTT CGCTCG | |||||
| F: AAA ATC GAT GGT AAA GGT TGG C | MK659556.1 | 58 | 532 | Kim et al.[ | |
| R: AGT TCT GCA GTA CCG GAT TTG C | |||||
| F: TGA CCA CTT TTA TCA GCA ACC | MN689952.1 | 58 | 700 | Meroni et al.[ | |
| R: GCC ATT TCA ACA CCT TCT TTC |
Antibiotic resistance profile of Escherichia coli isolates (n = 78) from bovine milk samples.
| Antimicrobial agent | Disk content | Interpretive categories and zone diameter breakpoints (nearest whole mm)* | No. of isolates (%) | ||||
|---|---|---|---|---|---|---|---|
| R** | I | S | R | I | S | ||
| Azithromycin | 15 μg | ≤ 12 | – | ≥ 13 | 53 (67.94) | – | 25 (32.05) |
| Chloramphenicol | 30 μg | ≤ 12 | 13–17 | ≥ 18 | 15 (19.23) | 2 (2.56) | 61 (78.20) |
| Ceftriaxone | 30 μg | ≤ 19 | 20–22 | ≥ 23 | 17 (21.79) | 14 (17.94) | 47 (60.25) |
| Penicillin | 10 IU | ≤ 14 | – | ≥ 15 | 69 (88.46) | – | 9 (11.53) |
| Gentamicin | 10 μg | ≤ 12 | 13–14 | ≥ 15 | 6 (7.69) | 3 (3.84) | 69 (88.46) |
| Amoxicillin | 25 μg | ≤ 13 | 14–16 | ≥ 17 | 55 (70.51) | 3 (3.84) | 20 (25.64) |
| Tetracycline | 30 μg | ≤ 11 | 12–14 | ≥ 15 | 20 (25.64) | 9 (11.53) | 49 (62.82) |
| Cephalexin | 30 μg | ≤ 14 | – | ≥ 15 | 64 (82.05) | – | 14 (17.94) |
*From CLSI[31].
**S susceptible, I intermediate, R resistant.
Distribution of resistance genes in the selected foodborne bacterial isolated from bovine milk.
| Target genes | No of isolates (%) | |||
|---|---|---|---|---|
| 5 (6.41%) | 4 (19.04) | – | – | |
| – | – | – | 3 (12.00) | |
| 39 (50%) | 6 (28.57) | – | – | |
| – | – | – | 5 (20.00) | |
Antibiotic resistance profile of Listeria monocytogenes isolates (n = 47) from bovine milk samples.
| Antimicrobial agent | Disk content | Interpretive categories and zone diameter breakpoints (nearest whole mm)* | No. of isolates (%) | ||||
|---|---|---|---|---|---|---|---|
| R** | I | S | R | I | S | ||
| Azithromycin | 15 μg | ˂ 17 | 17–21 | ≥ 22 | 12 (25.53) | 14 (29.78) | 21 (44.68) |
| Chloramphenicol | 30 μg | ˂ 18 | 18–20 | ≥ 21 | 22 (46.80) | 13 (27.65) | 12 (25.53) |
| Ceftriaxone | 30 μg | ˂ 15 | 15–20 | ≥ 21 | 17 (36.17) | 18 (38.29) | 12 (25.53) |
| Penicillin | 10 IU | < 8 | 8–28 | ≥ 29 | 46 (97.87) | 0 (0) | 1 (2.12) |
| Gentamicin | 10 μg | < 18 | 18–20 | ≥ 21 | 24 (51.06) | 21 (44.68) | 2 (4.25) |
| Amoxicillin | 25 μg | ˂ 14 | 14–24 | ≥ 25 | 46 (97.87) | 1 (2.12) | 0 (0) |
| Tetracycline | 30 μg | ˂ 22 | 22–24 | ≥ 25 | 23 (48.93) | 2 (4.25) | 22 (46.80) |
| Cephalexin | 30 μg | ˂ 12 | 12–17 | ≥ 18 | 46 (97.87) | 1 (2.12) | 0 (0) |
*From CA-SFM[59], CLSI[31], Hansen et al.[60], and Soussy et al.[61].
**S susceptible, I intermediate, R resistant.
Antibiotic resistance profile of Salmonella spp. isolates (n = 21) from bovine milk samples.
| Antimicrobial agent | Disk content | Interpretive categories and zone diameter breakpoints (nearest whole mm)* | No. of isolates (%) | ||||
|---|---|---|---|---|---|---|---|
| R** | I | S | R | I | S | ||
| Azithromycin | 15 μg | ≤ 12 | – | ≥ 13 | 8 (38.09) | – | 13 (61.90) |
| Chloramphenicol | 30 μg | ≤ 12 | 13–17 | ≥ 18 | 6 (28.57) | 1 (4.76) | 14 (66.66) |
| Ceftriaxone | 30 μg | ≤ 19 | 20–22 | ≥ 23 | 5 (23.80) | 3 (14.28) | 13 (61.90) |
| Penicillin | 10 IU | ≤ 14 | – | ≥ 15 | 21 (100) | – | 0 (0) |
| Gentamicin | 10 μg | ≤ 12 | 13–14 | ≥ 15 | 0 (0) | 0 (0) | 21 (100) |
| Amoxicillin | 25 μg | ≤ 13 | 14–16 | ≥ 17 | 15 (71.42) | 3 (14.28) | 3 (14.28) |
| Tetracycline | 30 μg | ≤ 11 | 12–14 | ≥ 15 | 5 (23.80) | 7 (33.33) | 9 (42.85) |
| Cephalexin | 30 μg | ≤ 14 | – | ≥ 15 | 21 (100) | – | 0 (0) |
*From CLSI[31].
**S susceptible, I intermediate, R resistant.
Antibiotic resistance profile of Staphylococcus aureus isolates (n = 25) from bovine milk samples.
| Antimicrobial agent | Disk content | Interpretive categories and zone diameter breakpoints (nearest whole mm)* | No. of isolates (%) | ||||
|---|---|---|---|---|---|---|---|
| R** | I | S | R | I | S | ||
| Azithromycin | 15 μg | ≤ 13 | 14–17 | ≥ 18 | 8 (32.00) | 8 (32.00) | 9 (36.00) |
| Chloramphenicol | 30 μg | ≤ 12 | 13–17 | ≥ 18 | 6 (24.00) | 13 (52.00) | 6 (24.00) |
| Ceftriaxone | 30 μg | ≤ 13 | 14–20 | ≥ 21 | 6 (24.00) | 12 (48.00) | 7 (28.00) |
| Penicillin | 10 IU | ≤ 28 | – | ≥ 29 | 21 (84.00) | – | 4 (16.00) |
| Gentamicin | 10 μg | ≤ 12 | 13–14 | ≥ 15 | 3 (12.00) | 21 (84.00) | 1 (4.00) |
| Amoxicillin | 25 μg | ≤ 28 | – | ≥ 29 | 25 (100) | – | 0 (0) |
| Tetracycline | 30 μg | ≤ 14 | 15–18 | ≥ 19 | 7 (28.00) | 11 (44.00) | 7 (28.00) |
| Cephalexin | 30 μg | ≤ 21 | – | ≥ 22 | 25 (100) | – | 0 (0) |
*From CA-SFM[59], CLSI[31].
**S susceptible, I intermediate, R resistant.
Figure 1Electrophoresis pattern obtained by multiplex PCR for detection of blaTEM and blaSHV genes in E. coli isolates. M: marker 100 bp; lane 1, 2, 3, 4, 5, 6, 7, 8, 9, 11: amplification of blaTEM gene at 516 bp; lane 6, 10: amplification of blaSHV gene at 392 bp.
Figure 2Electrophoresis pattern obtained by multiplex PCR for detection of blaTEM and blaSHV genes in Salmonella isolates. M: marker 100 bp; Lanes 2, 5, 6, 8, and 10: amplification of blaTEM gene at 516 bp; lane 2, 3, 6: amplification of blaSHV gene at 392 bp.
Figure 3Electrophoresis pattern obtained by multiplex PCR for detection of mecA and blaZ genes in S. aureus isolates. M: marker 100 bp; Lanes 5 and 9: amplification of mecA gene at 532 bp; lane 10: amplification of blaZgene at 700 bp.